Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
, develop and execute workshops and projects based on direction, needs, and input from the committee. This GSSA position is ideal for those who are interested in needs assessment, program development
-
agents or study interventions, as appropriate. Demonstrates expertise in participant assessment related to oncology (and related diseases) and treatment as evidenced by documentation and observation
-
more “AI-ready” designs? In this context, GenAI-based assistants (for understanding manuals, procedures, and logs) and agentic AI (for decomposing high-level operational goals into safe, ordered
-
, evidence-based treatment plans in dynamic critical care environments. Prescribes and titrates pharmacologic agents (including vasoactive infusions / vasopressors, sedatives, analgesics, paralytics
-
the areas of Cognitive Psychology, Cognitive Neuroscience, or Industrial-Organizational psychology. Area of methodological expertise is open and could include areas such as, but not limited to, agent-based
-
offer components are subject to additional approvals based on UC policy. Your placement within the salary range is dependent on a number of factors including your work experience and internal equity
-
research; establishes intravenous access; administers imaging contrast agents in accordance with applicable regulatory accreditation (e.g., ACR) and as directed by protocol under the supervision
-
management strategies using evidence-based medicine. · Facilitate referrals to other care providers. · Prescribe appropriate pharmacological agents. · Provide patient education and
-
, professional and productive manner. Knowledge of legal implications in clinical practice and professional development. Knowledge of performance improvement and evidence-based practice. Knowledge of and ability
-
to cancer therapeutics, target identification, mechanism-based pharmacology, or chemoprevention. We have a special interest in candidates focused on the development of novel agents for cancer-associated pain